US Stock MarketDetailed Quotes

RGC Regencell Bioscience

Watchlist

5.905
+0.035+0.60%

Close Nov 25 16:00 ET

6.220
+0.315+5.33%

Post 20:01 ET

76.84MMarket Cap-17893P/E (TTM)

Regencell Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

(FY)Dec 31, 2017

(Q4)Dec 31, 2017

(Q3)Sep 30, 2017

(Q2)Jun 30, 2017

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

19.37%-4M

5.77%-4.96M

-586.43%-5.27M

-5.61%-767.31K

-85.83%-726.57K

-390.99K

Net income from continuing operations

28.03%-4.36M

20.18%-6.06M

-463.92%-7.59M

-65.78%-1.35M

-107.77%-812.37K

---390.99K

-34.13%112.3M

-46.38%28.9M

-73.05%11.4M

-29.76%23.6M

Operating gains losses

----

--1.42K

----

66.32%-6.4M

75.00%-1.1M

-100.00%-16.8M

69.00%-3.1M

Depreciation and amortization

-3.13%745.59K

27.35%769.69K

2,184.54%604.4K

178.02%26.46K

--9.52K

--0

8.24%249.7M

6.54%63.5M

6.67%62.4M

10.54%62.9M

Deferred tax

----

-125.00%-600K

-98.11%100K

311.76%7M

-700.00%-3.2M

Other non cash items

-190.40%-248K

-695.68%-85.4K

---10.73K

----

4.38%14.3M

5.88%3.6M

2.70%3.8M

0.00%3.5M

Change In working capital

-15.02%-585.37K

50.30%-508.95K

-285.19%-1.02M

624.91%552.98K

--76.28K

--0

31.16%-46.4M

85.23%32.6M

67.67%-32.3M

-220.35%-148M

-Change in receivables

----

---27.7M

---111.3M

107.55%22M

-341.86%-38M

-Change in inventory

----

-186.67%-1.3M

325.00%900K

-70.00%600K

-300.00%-400K

-Change in prepaid assets

-269.01%-85.42K

77.88%-23.15K

-1,237.23%-104.63K

58.20%-7.82K

---18.72K

--0

-44.00%-3.6M

-28.33%4.3M

4,300.00%4.2M

-252.38%-7.4M

-Change in payables and accrued expense

-1,961.26%-34.88K

100.38%1.87K

-187.20%-489.03K

490.32%560.8K

--95K

--0

115.65%6.7M

16.45%106.2M

70.31%-21.2M

-2,203.03%-76M

-Change in other current liabilities

4.63%-465.07K

-13.30%-487.67K

---430.42K

--0

----

-Change in other working capital

----

13.14%-20.5M

-0.31%32.5M

7.56%-37.9M

19.14%-26.2M

Cash from discontinued investing activities

Operating cash flow

19.37%-4M

5.77%-4.96M

-586.43%-5.27M

-5.61%-767.31K

-85.83%-726.57K

---390.99K

-0.15%409.9M

-5.10%154.3M

425.27%47.8M

-172.07%-41.8M

Investing cash flow

Cash flow from continuing investing activities

8,789.12%5.24M

100.55%58.98K

-10.78M

-117.84K

Capital expenditure reported

----

-16.52%-250.4M

-25.25%-74.9M

-8.37%-71.2M

-2.23%-59.6M

Net PPE purchase and sale

79.65%-5.38K

96.62%-26.42K

---780.88K

--0

---117.84K

--0

----

Net business purchase and sale

----

-1,164.23%-173.2M

290.00%9.5M

90.00%-400K

-4,415.00%-180.6M

Net investment purchase and sale

6,045.20%5.25M

100.85%85.4K

---10M

--0

----

--10.3M

--0

Net other investing changes

----

828.57%13M

-7,400.00%-7.3M

--8.5M

--0

Cash from discontinued investing activities

Investing cash flow

8,789.12%5.24M

100.55%58.98K

---10.78M

--0

---117.84K

--0

-83.63%-410.6M

-12.36%-72.7M

24.25%-52.8M

-285.55%-240.2M

Financing cash flow

Cash flow from continuing financing activities

-24.19%102.28K

-99.40%134.91K

4,995.12%22.41M

-55.50%439.75K

105.43%988.08K

480.99K

Net issuance payments of debt

--0

-170.58%-431.97K

-38.06%612.06K

105.43%988.08K

--480.99K

682.95%126.5M

-65.96%-7.8M

8.57%-6.4M

4,829.03%146.6M

Net common stock issuance

--0

--22.67M

--0

----

Cash dividends paid

----

0.00%-138.9M

0.00%-34.5M

-0.29%-34.6M

0.00%-34.5M

Net other financing activities

-24.19%102.28K

-17.74%134.91K

195.18%164K

---172.31K

----

-866.67%-4.6M

--0

-270.00%-3.4M

Cash from discontinued financing activities

Financing cash flow

-24.19%102.28K

-99.40%134.91K

4,995.12%22.41M

-55.50%439.75K

105.43%988.08K

--480.99K

89.38%-17M

-10.44%-42.3M

-0.99%-41M

405.34%108.7M

Net cash flow

Beginning cash position

-75.61%1.56M

10,700.66%6.42M

-84.65%59.41K

59.05%386.98K

58.71%243.31K

--153.3K

12.25%246.5M

1.39%189.5M

-18.26%235.5M

24.63%408.8M

Current changes in cash

128.17%1.34M

-175.01%-4.77M

2,040.86%6.36M

-328.00%-327.57K

59.63%143.67K

--90K

-165.80%-17.7M

-34.06%39.3M

54.55%-46M

-334.34%-173.3M

Effect of exchange rate changes

164.01%53.22K

---83.15K

--0

----

End cash Position

89.24%2.96M

-75.61%1.56M

10,700.66%6.42M

-84.65%59.41K

59.05%386.98K

--243.31K

-7.18%228.8M

1.39%189.5M

-18.26%235.5M

Free cash flow

19.70%-4.01M

17.49%-4.99M

-688.20%-6.05M

9.13%-767.31K

-115.97%-844.41K

---390.99K

-18.46%159.5M

-22.76%79.4M

58.66%-23.4M

-33,700.00%-101.4M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019	(FY)Dec 31, 2017	(Q4)Dec 31, 2017	(Q3)Sep 30, 2017	(Q2)Jun 30, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	19.37%-4M	5.77%-4.96M	-586.43%-5.27M	-5.61%-767.31K	-85.83%-726.57K	-390.99K
Net income from continuing operations	28.03%-4.36M	20.18%-6.06M	-463.92%-7.59M	-65.78%-1.35M	-107.77%-812.37K	---390.99K	-34.13%112.3M	-46.38%28.9M	-73.05%11.4M	-29.76%23.6M
Operating gains losses	----	--1.42K	----	----	----	----	66.32%-6.4M	75.00%-1.1M	-100.00%-16.8M	69.00%-3.1M
Depreciation and amortization	-3.13%745.59K	27.35%769.69K	2,184.54%604.4K	178.02%26.46K	--9.52K	--0	8.24%249.7M	6.54%63.5M	6.67%62.4M	10.54%62.9M
Deferred tax	----	----	----	----	----	----	-125.00%-600K	-98.11%100K	311.76%7M	-700.00%-3.2M
Other non cash items	-190.40%-248K	-695.68%-85.4K	---10.73K	----	----	----	4.38%14.3M	5.88%3.6M	2.70%3.8M	0.00%3.5M
Change In working capital	-15.02%-585.37K	50.30%-508.95K	-285.19%-1.02M	624.91%552.98K	--76.28K	--0	31.16%-46.4M	85.23%32.6M	67.67%-32.3M	-220.35%-148M
-Change in receivables	----	----	----	----	----	----	---27.7M	---111.3M	107.55%22M	-341.86%-38M
-Change in inventory	----	----	----	----	----	----	-186.67%-1.3M	325.00%900K	-70.00%600K	-300.00%-400K
-Change in prepaid assets	-269.01%-85.42K	77.88%-23.15K	-1,237.23%-104.63K	58.20%-7.82K	---18.72K	--0	-44.00%-3.6M	-28.33%4.3M	4,300.00%4.2M	-252.38%-7.4M
-Change in payables and accrued expense	-1,961.26%-34.88K	100.38%1.87K	-187.20%-489.03K	490.32%560.8K	--95K	--0	115.65%6.7M	16.45%106.2M	70.31%-21.2M	-2,203.03%-76M
-Change in other current liabilities	4.63%-465.07K	-13.30%-487.67K	---430.42K	--0	--0	----	----	----	----	----
-Change in other working capital	----	----	----	----	----	----	13.14%-20.5M	-0.31%32.5M	7.56%-37.9M	19.14%-26.2M
Cash from discontinued investing activities
Operating cash flow	19.37%-4M	5.77%-4.96M	-586.43%-5.27M	-5.61%-767.31K	-85.83%-726.57K	---390.99K	-0.15%409.9M	-5.10%154.3M	425.27%47.8M	-172.07%-41.8M
Investing cash flow
Cash flow from continuing investing activities	8,789.12%5.24M	100.55%58.98K	-10.78M	0	-117.84K	0
Capital expenditure reported	----	----	----	----	----	----	-16.52%-250.4M	-25.25%-74.9M	-8.37%-71.2M	-2.23%-59.6M
Net PPE purchase and sale	79.65%-5.38K	96.62%-26.42K	---780.88K	--0	---117.84K	--0	----	----	----	----
Net business purchase and sale	----	----	----	----	----	----	-1,164.23%-173.2M	290.00%9.5M	90.00%-400K	-4,415.00%-180.6M
Net investment purchase and sale	6,045.20%5.25M	100.85%85.4K	---10M	--0	--0	----	----	----	--10.3M	--0
Net other investing changes	----	----	----	----	----	----	828.57%13M	-7,400.00%-7.3M	--8.5M	--0
Cash from discontinued investing activities
Investing cash flow	8,789.12%5.24M	100.55%58.98K	---10.78M	--0	---117.84K	--0	-83.63%-410.6M	-12.36%-72.7M	24.25%-52.8M	-285.55%-240.2M
Financing cash flow
Cash flow from continuing financing activities	-24.19%102.28K	-99.40%134.91K	4,995.12%22.41M	-55.50%439.75K	105.43%988.08K	480.99K
Net issuance payments of debt	--0	--0	-170.58%-431.97K	-38.06%612.06K	105.43%988.08K	--480.99K	682.95%126.5M	-65.96%-7.8M	8.57%-6.4M	4,829.03%146.6M
Net common stock issuance	--0	--0	--22.67M	--0	--0	----	----	----	----	----
Cash dividends paid	----	----	----	----	----	----	0.00%-138.9M	0.00%-34.5M	-0.29%-34.6M	0.00%-34.5M
Net other financing activities	-24.19%102.28K	-17.74%134.91K	195.18%164K	---172.31K	----	----	-866.67%-4.6M	--0	--0	-270.00%-3.4M
Cash from discontinued financing activities
Financing cash flow	-24.19%102.28K	-99.40%134.91K	4,995.12%22.41M	-55.50%439.75K	105.43%988.08K	--480.99K	89.38%-17M	-10.44%-42.3M	-0.99%-41M	405.34%108.7M
Net cash flow
Beginning cash position	-75.61%1.56M	10,700.66%6.42M	-84.65%59.41K	59.05%386.98K	58.71%243.31K	--153.3K	12.25%246.5M	1.39%189.5M	-18.26%235.5M	24.63%408.8M
Current changes in cash	128.17%1.34M	-175.01%-4.77M	2,040.86%6.36M	-328.00%-327.57K	59.63%143.67K	--90K	-165.80%-17.7M	-34.06%39.3M	54.55%-46M	-334.34%-173.3M
Effect of exchange rate changes	164.01%53.22K	---83.15K	--0	--0	----	----	----	----	----	----
End cash Position	89.24%2.96M	-75.61%1.56M	10,700.66%6.42M	-84.65%59.41K	59.05%386.98K	--243.31K	-7.18%228.8M	-7.18%228.8M	1.39%189.5M	-18.26%235.5M
Free cash flow	19.70%-4.01M	17.49%-4.99M	-688.20%-6.05M	9.13%-767.31K	-115.97%-844.41K	---390.99K	-18.46%159.5M	-22.76%79.4M	58.66%-23.4M	-33,700.00%-101.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data